Premier (PINC) Competitors $22.23 -0.07 (-0.31%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends PINC vs. EVH, FC, MANT, TMX, RCM, MARA, BILI, LYFT, QXO, and ETSYShould you be buying Premier stock or one of its competitors? The main competitors of Premier include Evolent Health (EVH), Franklin Covey (FC), ManTech International (MANT), Terminix Global (TMX), R1 RCM (RCM), MARA (MARA), Bilibili (BILI), Lyft (LYFT), QXO (QXO), and Etsy (ETSY). Premier vs. Evolent Health Franklin Covey ManTech International Terminix Global R1 RCM MARA Bilibili Lyft QXO Etsy Evolent Health (NYSE:EVH) and Premier (NASDAQ:PINC) are both computer and technology companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, community ranking, valuation, profitability, dividends, media sentiment, risk and earnings. Which has more risk & volatility, EVH or PINC? Evolent Health has a beta of 1.58, meaning that its share price is 58% more volatile than the S&P 500. Comparatively, Premier has a beta of 0.4, meaning that its share price is 60% less volatile than the S&P 500. Does the media favor EVH or PINC? In the previous week, Evolent Health had 4 more articles in the media than Premier. MarketBeat recorded 9 mentions for Evolent Health and 5 mentions for Premier. Premier's average media sentiment score of 0.74 beat Evolent Health's score of 0.18 indicating that Premier is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Evolent Health 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral Premier 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders believe in EVH or PINC? 74.4% of Premier shares are owned by institutional investors. 1.6% of Evolent Health shares are owned by company insiders. Comparatively, 1.0% of Premier shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has stronger valuation & earnings, EVH or PINC? Premier has lower revenue, but higher earnings than Evolent Health. Evolent Health is trading at a lower price-to-earnings ratio than Premier, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEvolent Health$2.46B0.54-$113.04M-$0.91-12.53Premier$1.35B1.59$119.54M$1.3616.35 Is EVH or PINC more profitable? Premier has a net margin of 11.41% compared to Evolent Health's net margin of -2.93%. Premier's return on equity of 10.74% beat Evolent Health's return on equity.Company Net Margins Return on Equity Return on Assets Evolent Health-2.93% 6.30% 2.57% Premier 11.41%10.74%6.36% Do analysts recommend EVH or PINC? Evolent Health presently has a consensus target price of $28.90, suggesting a potential upside of 153.51%. Premier has a consensus target price of $21.36, suggesting a potential downside of 3.93%. Given Evolent Health's stronger consensus rating and higher possible upside, research analysts clearly believe Evolent Health is more favorable than Premier.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Evolent Health 0 Sell rating(s) 1 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 3.00Premier 0 Sell rating(s) 9 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the MarketBeat Community favor EVH or PINC? Premier received 55 more outperform votes than Evolent Health when rated by MarketBeat users. However, 74.30% of users gave Evolent Health an outperform vote while only 68.19% of users gave Premier an outperform vote. CompanyUnderperformOutperformEvolent HealthOutperform Votes55874.30% Underperform Votes19325.70% PremierOutperform Votes61368.19% Underperform Votes28631.81% SummaryPremier beats Evolent Health on 10 of the 19 factors compared between the two stocks. Ad Darwin2025 AI Stock Picks: 2 Hidden Gems Under $10/ShareThe AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.👉[Click here to get your FREE report delivered instantly!] Get Premier News Delivered to You Automatically Sign up to receive the latest news and ratings for PINC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PINC vs. The Competition Export to ExcelMetricPremierManagement services IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.14B$7.82B$5.07B$8.90BDividend Yield3.77%3.31%4.99%4.07%P/E Ratio16.3510.6987.8613.46Price / Sales1.592.201,228.8287.66Price / Cash6.1315.5239.5136.27Price / Book1.098.446.946.30Net Income$119.54M$156.61M$119.12M$225.93M7 Day Performance-2.29%-3.72%-1.84%-1.32%1 Month Performance11.88%-8.26%-3.65%0.60%1 Year Performance5.21%-5.34%31.64%26.23% Premier Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PINCPremier3.2124 of 5 stars$22.23-0.3%$21.36-3.9%+5.7%$2.14B$1.35B16.352,900EVHEvolent Health3.5821 of 5 stars$11.40+0.8%$28.90+153.5%-61.3%$1.33B$2.46B-12.414,700Analyst ForecastFCFranklin Covey4.1727 of 5 stars$35.48+0.5%$63.33+78.5%-10.0%$467.63M$287.23M20.281,084Short Interest ↓MANTManTech InternationalN/A$95.98flatN/A+0.0%$3.93B$2.55B32.329,800TMXTerminix Global0.3916 of 5 stars$37.87flatN/AN/A$4.61B$2.05B71.4511,700RCMR1 RCM3.181 of 5 stars$14.31flat$15.41+7.7%N/A$6.04B$2.25B0.0030,000News CoverageMARAMARA2.7505 of 5 stars$24.42+7.9%$22.57-7.6%+112.7%$7.86B$387.51M28.659Analyst ForecastInsider TradeOptions VolumeGap UpBILIBilibili2.2522 of 5 stars$18.80-2.0%$19.69+4.7%+31.7%$7.79B$3.19B-20.868,801Earnings ReportAnalyst ForecastGap UpLYFTLyft3.9777 of 5 stars$16.71-0.4%$17.48+4.6%+61.4%$6.93B$4.40B0.002,945QXOQXO0.9892 of 5 stars$15.99+0.6%N/AN/A$6.55B$54.52M-1.75195News CoverageETSYEtsy4.6099 of 5 stars$50.95+0.2%$64.87+27.3%-29.4%$5.73B$2.75B25.952,420 Related Companies and Tools Related Companies Evolent Health Alternatives Franklin Covey Alternatives ManTech International Alternatives Terminix Global Alternatives R1 RCM Alternatives MARA Alternatives Bilibili Alternatives Lyft Alternatives QXO Alternatives Etsy Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PINC) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Premier, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Premier With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.